About H.U. Group Holdings
H.U. Group Holdings is a company based in Shinjuku (Japan) founded in 1950.. The company has 5,440 employees as of March 31, 2024. H.U. Group Holdings operates in a competitive market with competitors including PPD, Cambrian BioPharma, Medicus Pharma, DM Clinical and IPHARMA, among others.
- Headquarter Shinjuku, Japan
- Employees 5440 as on 31 Mar, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
- Legal Name H.U.Group Holdings, Inc.
-
Annual Revenue
$1.63 B (USD)2.56as on Mar 31, 2025
-
Net Profit
$18.47 M (USD)0as on Mar 31, 2025
-
EBITDA
$154.52 M (USD)37.24as on Mar 31, 2025
-
Latest Funding Round
-
Investors
-
Employee Count
5440
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of H.U. Group Holdings
H.U. Group Holdings is a publicly listed company on the TSE with ticker symbol 4544 in Japan, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of H.U. Group Holdings
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by H.U. Group Holdings
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - H.U. Group Holdings
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
H.U. Group Holdings Comparisons
Competitors of H.U. Group Holdings
H.U. Group Holdings operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PPD, Cambrian BioPharma, Medicus Pharma, DM Clinical and IPHARMA, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
CRO providing diversified clinical development services
|
|
| domain | founded_year | HQ Location |
Medicines and therapies are developed for healthcare applications.
|
|
| domain | founded_year | HQ Location |
Clinical stage, multi-strategy holding company focused on investing in and accelerating novel therapies in the biotechnology and life sciences industry
|
|
| domain | founded_year | HQ Location |
Conducts Phase I-IV clinical trials connecting patients with physicians for medical research.
|
|
| domain | founded_year | HQ Location |
Serves as a contract research organization focused on drug clinical trials.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on H.U. Group Holdings
Frequently Asked Questions about H.U. Group Holdings
When was H.U. Group Holdings founded?
H.U. Group Holdings was founded in 1950.
Where is H.U. Group Holdings located?
H.U. Group Holdings is headquartered in Shinjuku, Japan. It is registered at Shinjuku, Tokyo, Japan.
How many employees does H.U. Group Holdings have?
As of Mar 31, 2024, the latest employee count at H.U. Group Holdings is 5,440.
What is the annual revenue of H.U. Group Holdings?
Annual revenue of H.U. Group Holdings is $1.63B as on Mar 31, 2025.
What does H.U. Group Holdings do?
H.U. Group Holdings was founded in 1950 and is headquartered in Shinjuku, Japan. Operations in the healthcare sector focus on laboratory testing, in-vitro diagnostics, and related services. Research and development efforts support clinical laboratory medicine and technological progress in medical science. Intellectual property management is handled, alongside initiatives for public health issues. Services extend to broader healthcare support across the region.
Who are the top competitors of H.U. Group Holdings?
H.U. Group Holdings's top competitors include PPD, Cambrian BioPharma and Medicus Pharma.
Is H.U. Group Holdings publicly traded?
Yes, H.U. Group Holdings is publicly traded on TSE under the ticker symbol 4544.
What is H.U. Group Holdings's ticker symbol?
The ticker symbol of H.U. Group Holdings is 4544 on TSE.